STAT

JULY 11, 2024

Alcohol has long been classified as a cancer-causing substance, but a study out Thursday gives a clearer sense of just how many cancer cases and deaths may be driven by drinking.  Researchers from the American Cancer Society and International Agency for Research on Cancer estimate 40% of all cancer cases in the United States in people 30 and up were due to “potentially modifiable risk factors,” including cigarette smoking, physical inactivity, consumption of processed meat, vi

364

364

PharmaVoice

JULY 11, 2024

Drugmakers pointed the finger at PBMs for being the culprit behind rising drug prices in the U.S. for years — now, an ongoing FTC investigation has their back.

Drug Pricing 130

Drug Pricing 130

STAT

JULY 11, 2024

A key part of the federal government’s narrative about the epidemic of addiction and overdose deaths in the U.S. has been that it is driven by doctors and other clinicians overprescribing opioid painkillers. That story line is false — and was never true. The Centers for Disease Control and Prevention has traditionally relied on death certificate data compiled by the National Center for Health Statistics for its data on overdose deaths, organized as Underlying Cause of Death data us

364

364

BioPharma Dive

JULY 11, 2024

Far behind companies like Novo and Eli Lilly, Pfizer hopes the version of the drug, danuglipron, that it’s chosen to advance can break into the ultra-lucrative market for weight-loss medicines.

127

127

Speaker: Joe Sharpe and James Carlson

In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.

STAT

JULY 11, 2024

As Covid-19 swept across the United States, schools were among the most highly affected public spaces. To prepare for a potential H5N1 avian influenza jump to humans, schools need to be preparing for the scenario now before a sustained transmission event occurs. The response to Covid-19, which first appeared in the U.S. in early 2020, has been scrutinized by numerous case studies, after-action reports , and Congressional fact-finding hearings.

363

363

pharmaphorum

JULY 11, 2024

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.Lawmakers unanimously passed the Affordable Prescriptions for Patients Act of 2023 (S-150), which is part of a lengthening list of measures being taken by Congress to curb the prices of medicines in the US.

Biosimilars 118

Biosimilars 118

European Pharmaceutical Review

JULY 11, 2024

Dr Roopal Thakkar has been appointed as Executive Vice President, Research & Development and Chief Scientific Officer of AbbVie. He is the company ’s current Senior Vice President, Chief Medical Officer, Global Therapeutics. “As AbbVie’s Chief Scientific Officer, Dr Thakkar will continue to build momentum across discovery and all stages of development to fully realise the potential of our diverse pipeline.

105

105

STAT

JULY 11, 2024

WASHINGTON — When Elmo asked “How is everybody doing?” back in January, he was not expecting the onslaught of stress, despair, and anxiety that hit his replies. “I’m just looking for somebody to talk to and show me some love if you know what I mean,” famous singer T-Pain wrote back to the red Muppet.

361

361

Outsourcing Pharma

JULY 11, 2024

Ketaki Patwardhan, a global technical developer at Roquette, has built a remarkable career in the pharmaceutical industry by leveraging her curiosity and passion for science.

105

105

STAT

JULY 11, 2024

Pfizer said Thursday that it plans to advance a new, once-a-day formulation of its experimental obesity drug danuglipron, meant to be a pill version in the same class as popular injections like Wegovy and Zepbound. The medicine had at one point been a key focus for many investors, with Pfizer talking up the potential of the obesity market and saying it had two potential experimental obesity medicines in development.

Diabetes 312

Diabetes 312

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

JULY 11, 2024

The US Food and Drug Administration has declined to approve Novo Nordisk’s weekly insulin in patients with diabetes, the Danish drugmaker said on Wednesday. The health regulator in its so-called “complete response letter” sought more information related to the manufacturing process and the type 1 diabetes indication to complete the review, Novo said.

Diabetes 102

Diabetes 102

STAT

JULY 11, 2024

In what could prove to be a lifeline for a new crop of health tech startups, Medicare regulators proposed new codes that support payment for digital mental health treatments, like apps that deliver cognitive behavioral therapy. The new codes  in the Centers for Medicare and Medicaid Services’ 2025 Medicare Physician Fee Schedule Proposed Rule released this week would allow clinicians to bill for supplying apps and other digital treatments as part of behavioral health treatment, as we

301

301

pharmaphorum

JULY 11, 2024

The rise of GenAI is revolutionising the field of pharma medical writing in biopharma. Explore how this innovative technology is transforming the industry and its impact on medical writing practices.

102

102

STAT

JULY 11, 2024

Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout out as its next science chief? STAT’s West Coast biotech reporter Jonathan Wosen joins “The Readout LOUD” to discuss what’s driving workforce cuts.

Pharmaceutical Companies 275

Pharmaceutical Companies Pharmaceutical Companies Diabetes 275

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JULY 11, 2024

The FTC is said to be gearing up to file lawsuits against the top three pharmacy benefit managers in the wake of its damning report on the sector.

112

112

STAT

JULY 11, 2024

Rise and shine, another busy day is on the way. However, this is also shaping up as a beautiful day as well, despite expectations of still more heat. The skies are clear and sunny, the birds are chirping, and the official mascots are capturing creatures on the Pharmalot campus this morning. This calls for celebration with a cup of stimulation, and we are opening a new package of blueberry muffin for the occasion.

Diabetes 228

Diabetes Packaging 228

BioPharma Dive

JULY 11, 2024

The Supreme Court’s decision to overturn the Chevron doctrine would make it easier to challenge agency regulations, such as the LDT final rule.

111

111

STAT

JULY 11, 2024

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here to get it delivered to their inbox. A few years back, TIGIT was hailed as the next blockbuster target for cancer immunotherapy. Based on early data, drugmakers were hopeful that blocking two checkpoint proteins on immune cells — TIGIT and PD-1/PD-L1 — would be more effective at killing tumors than just blocking one, potentially offering greater benef

Immunity 226

Immunity Immunization 226

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Patent Watch

JULY 11, 2024

The value proposition of Contract Development and Manufacturing Organizations (CDMOs) has become increasingly crucial in the pharmaceutical industry.

111

111

STAT

JULY 11, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. We’ve got lots of news this morning, so let’s get straight into it.

Drug Pricing 198

Drug Pricing Drug Development 198

Pharma Times

JULY 11, 2024

Macmillan Cancer Support estimates that cancer affects over three million people in the UK

130

130

Drug Patent Watch

JULY 11, 2024

In the high-stakes world of biosimilar development, manufacturers are increasingly turning to an unexpected partner: the Patent Trial and Appeal […] Source

Biosimilars 104

Biosimilars 104

pharmaphorum

JULY 11, 2024

Tune in to Caroline Redecker and Jason Casarella as they discuss clinical trial trends and the rise of site networks in this insightful podcast episode brought to you by Advanced Clinical.

96

96

World Pharma News

JULY 11, 2024

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track Designation for AB-1005, which is being developed for moderate Parkinson's disease. AB-1005 has also been awarded the Innovation Passport, the United Kingdom Medicines and Healthcare products Regulatory Agency (UK MHRA) innovative medicine designa

96

96

Express Pharma

JULY 11, 2024

Zydus Lifesciences has received final approval from the United States Food and Drug Administration to market Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg (USRLD: Entresto tablets). Sacubitril and Valsartan combination is used to treat chronic heart failure in adults to help reduce the risk of death and hospitalisation.

95

95

Outsourcing Pharma

JULY 11, 2024

In an exclusive interview, Akash Bakshi, CEO of YourChoice Therapeutics, delves into the inspiration and journey behind developing a hormone-free birth control pill for men.

95

95

Express Pharma

JULY 11, 2024

Indegene announced a strategic collaboration with Microsoft to empower global life sciences companies to scale up the adoption of purpose-built, enterprise-grade Generative AI services, thereby driving faster innovation at scale. Indegene and Microsoft have aimed to develop resources in highly specialised and skilled medical and technology tools to co-innovate generative AI services and workflows across commercial, medical, regulatory, and clinical functions.

Documentation 91

Documentation 91

pharmaphorum

JULY 11, 2024

FDA rejects Novo Nordisk’s once-weekly basal insulin for people with diabetes, which would reduce the number of injections needed

Diabetes 105

Diabetes 105

Express Pharma

JULY 11, 2024

Season 2 of the Express Pharma – Nutrify Today Boardroom series presents key dialogues from the Nutrify C Suite Sumflex 2024, held over June 6-7, 2024. In this video, industry leaders discuss the importance of adding D (development) capabilities for nutraceutical contract manufacturing organisations (CMOs). [+] Neetu Sharma, Advisor, BD Nutraceuticals (Moderator) [+] Suresh Garg, Managing Director, Zeon Life Sciences [+] Subba Rao MD, Managing Director, Crius Life Sciences [+] Rajiv Sanghvi, CEO

88

88

pharmaphorum

JULY 11, 2024

SK Life Science Leverages Smart, Efficient Solutions Across its Engaged Industry-Leading Sales Team Mike.

108

108

Express Pharma

JULY 11, 2024

The Startup Incubation and Innovation Centre (SIIC) at the Indian Institute of Technology Kanpur (IITK) has signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim India, to advance solutions in the field of dementia care. The Boehringer Ingelheim India team, comprising Gagandeep Singh Bedi, MD and, Prabhat Sinha, Director of Government and Public Affairs, Corporate Affairs, visited SIIC, IIT Kanpur, to strengthen their partnership in fostering healthcare innovations.

82

82

Pharma Times

JULY 11, 2024

The ESRC EquaDem Network Plus aims to improve disparities in diagnosis and care

112

112

The Pharmacist

JULY 11, 2024

Community pharmacies provide the most essential service for local people, according to a survey by the Association of Convenience Stores (ACS). The 2024 Community Barometer report surveyed 2,000 UK adults about their reliance on a range of services including convenience stores, pharmacies, post offices and banks. As well as topping the list for essential services, […] The post Pharmacies offer ‘most essential local service’, report finds appeared first on The Pharmacist.

Community Pharmacies 84

Community Pharmacies 84